A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)

BACKGROUND: In Japan, there are limited options for switching opioid analgesics. Hydromorphone is an opioid analgesic that is routinely used instead of morphine for cancer pain; however, it is not yet available in Japan. The aim of this study was to assess the efficacy and safety of hydromorphone (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Satoshi, Saito, Yoji, Tsuneto, Satoru, Aruga, Etsuko, Ide, Azusa, Kakurai, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571837/
https://www.ncbi.nlm.nih.gov/pubmed/28860850
http://dx.doi.org/10.2147/JPR.S136937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571837/
https://www.ncbi.nlm.nih.gov/pubmed/28860850
http://dx.doi.org/10.2147/JPR.S136937

Ejemplares similares